[1]
N. Watanabe, “Crizotinib-induced acute interstitial lung disease in a patient with EML4-ALK positive non-small cell lung cancer and chronic interstitial pneumonia”, AO, vol. 53, no. 1, pp. 158–160, Jan. 2014.